To stop or not to stop: That is the question, but what is the answer?

被引：17

作者：

Hogg, RS ^{[1
]}

Havlir, D

Miller, V

Montaner, JSG

机构：

[1] BC Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada

[2] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA

[3] George Washington Univ, Ctr Hlth Serv Res Policy, Washington, DC USA

来源：

AIDS | 2002年 / 16卷 / 05期

关键词：

treatment interruption; HIV; antiretroviral therapy; disease progression;

D O I：

10.1097/00002030-200203290-00015

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 [免疫学];

摘要：

引用

页码：787 / 789

页数：3

共 34 条

[1]

ALFELD M, 2001, 8 C RETR OPP INF CHI

[2]

*BRIT HIV ASS, 2000, HIV MED, V1, P76

[3]

Antiretroviral therapy in adults - Updated recommendations of the International AIDS Society-USA Panel [J].

Carpenter, CCJ ;

Cooper, DA ;

Fischl, MA ;

Gatell, JM ;

Gazzard, BG ;

Hammer, SM ;

Hirsch, MS ;

Jacobsen, DM ;

Katzenstein, DA ;

Montaner, JSG ;

Richman, DD ;

Saag, MS ;

Schechter, M ;

Schooley, RT ;

Vella, S ;

Yeni, PG ;

Volberding, PA .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (03) :381-390

[4]

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors [J].

Carr, A ;

Samaras, K ;

Burton, S ;

Law, M ;

Freund, J ;

Chisholm, DJ ;

Cooper, DA .

AIDS, 1998, 12 (07) :F51-F58

[5]

Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance [J].

Carr, A ;

Samaras, K ;

Chisholm, DJ ;

Cooper, DA .

LANCET, 1998, 351 (9119) :1881-1883

[6]

Chen R, 2001, 8 C RETR OPP INF CHI

[7]

Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia. [J].

Deeks, SG ;

Wrin, T ;

Liegler, T ;

Hoh, R ;

Hayden, M ;

Barbour, JD ;

Hellmann, NS ;

Petropoulos, CJ ;

McCune, JM ;

Hellerstein, MK ;

Grant, RM .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (07) :472-480

[8]

Devereux HL, 1999, AIDS, V13, pF123, DOI 10.1097/00002030-199912240-00001

[9]

FAUCI A, 2001, 1 IAS C HIV PATH TRE

[10]

Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy [J].

Finzi, D ;

Blankson, J ;

Siliciano, JD ;

Margolick, JB ;

Chadwick, K ;

Pierson, T ;

Smith, K ;

Lisziewicz, J ;

Lori, F ;

Flexner, C ;

Quinn, TC ;

Chaisson, RE ;

Rosenberg, E ;

Walker, B ;

Gange, S ;

Gallant, J ;

Siliciano, RF .

NATURE MEDICINE, 1999, 5 (05) :512-517

← 1 2 3 4 →